ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1224

‘No Route Map’: The Complex Healthcare Journeys of People with Fibromyalgia – a Record Linkage Study in the UK

Rosemary Hollick, Ka-Kin Lam, Marcus Beasley, Gareth Jones, Corri Black and Gary Macfarlane, University of Aberdeen, Aberdeen, Scotland, United Kingdom

Meeting: ACR Convergence 2022

Keywords: Access to care, fibromyalgia, Health Care, Health Services Research, informatics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Healthcare services for persons with fibromyalgia (FM) lack co-ordination. Patients describe feeling ‘invisible’ within healthcare systems and often report poor experiences of care, particularly after diagnosis. As part of a program to design improved care models for people with FM within the UK National Health Service, we explored survey respondents’ secondary healthcare referral history. Specifically, we aimed to determine incidence of outpatient visits to different specialties, and frequency and direction of “transition” from one specialty to another, before and after diagnosis.

Methods: A previous study mailed questionnaires to adults registered at 16 GP practices in Scotland. Respondents reporting FM features were re-surveyed in 2019 and asked if they had ever received a FM diagnosis, and if so, in what year. Outpatient secondary care attendance records for these patients were available from the population-based Scottish hospital registry for 2006 through 2019. Proportion of FM patients visiting each specialty in this period was calculated. Average number of annual specialty visits per person was calculated for FM patients, before and after diagnosis, and compared with respondents meeting criteria for FM but with no diagnosis. Incidence rates per 1000 person-years pre- and post-diagnosis were computed. Frequency of repeat consultations, and transition between specialties (i.e., when referral to Specialty A is followed by referral to Specialty B) was recorded and the proportion of patients having each transition calculated for 5 years pre- and post-diagnosis.

Results: 72 patients with a FM diagnosis were included (61 female, mean age 57 years). The most visited specialties were General Surgery, Trauma & Orthopaedic Surgery, Rheumatology, Neurology, and Gynaecology (Table 1). The average number of annual specialty visits per person in those with FM was 1.4 before and 1.0 after diagnosis, and 1.1 in those who met criteria but without a diagnosis. Specialties most visited immediately before diagnosis (i.e. highest incidence rate of last visit pre-diagnosis) were Rheumatology and Trauma & Orthopaedic Surgery (89.8 and 81.1 visits per 1000 person-years) (Fig. 1). Pre-diagnosis, repeat visits to Trauma & Orthopaedics were common (22.2%). Specialties most visited immediately post-diagnosis were General Surgery, Gynaecology, and Pain Management (87.1, 86.9, and 60.0 visits per 1000 person-years). Post-diagnosis, patients visited many different clinics, with repeat visits to Pain Management just as common as those to Gastroenterology or General Surgery (11.4%).

Conclusion: We have illustrated complex healthcare journeys of FM patients. Pre-diagnostic journeys often end with visits to Rheumatology. Referrals post-diagnosis are also common, particularly to Gynaecology and General Surgery. There is a need for clear care pathways to; enable general practitioners to make a timely diagnosis, reduce unnecessary referrals, raise awareness among commonly visited specialties, and provide guidance on when to refer to services such as rheumatology in case of diagnostic uncertainty. This provides a basis from which to assess service change and design services which focus on support for pain management.

Supporting image 1

Table 1: Specialty referral in patients with an FM diagnosis in the period 2006 to 2019 (n=72)

Supporting image 2

Figure 1: Specialty incidence rate per 1000 person-years at risk immediately pre- and post-diagnosis date


Disclosures: R. Hollick, None; K. Lam, None; M. Beasley, None; G. Jones, AbbVie/Abbott, Pfizer, UCB, Amgen, GlaxoSmithKlein(GSK), Janssen; C. Black, None; G. Macfarlane, AbbVie/Abbott, Pfizer, UCB, Amgen, GlaxoSmithKlein(GSK).

To cite this abstract in AMA style:

Hollick R, Lam K, Beasley M, Jones G, Black C, Macfarlane G. ‘No Route Map’: The Complex Healthcare Journeys of People with Fibromyalgia – a Record Linkage Study in the UK [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/no-route-map-the-complex-healthcare-journeys-of-people-with-fibromyalgia-a-record-linkage-study-in-the-uk/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/no-route-map-the-complex-healthcare-journeys-of-people-with-fibromyalgia-a-record-linkage-study-in-the-uk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology